Health ❯ Healthcare

Patient Care

Treatment Options Hospitalization Emergency Services Chronic Conditions Quality of Life Chronic Illness Diagnosis Chronic Illness Management Access to Care Treatment Efficacy

Colin Mochrie Has Emergency Eye Surgery, Prompting HYPROV Postponements

His manager reports he is resting, with doctors expecting a full recovery.

Marisa Abela Says She’s Cancer-Free After Thyroid Treatment

Zenas' Obexelimab Meets Phase 3 Goals in IgG4-Related Disease With 56% Flare Risk Cut

Barry Manilow Shares Upbeat Hospital Selfie After Early Lung Cancer Diagnosis

NYSNA Issues 10-Day Strike Notices for 20,000 Nurses at 15 New York Hospitals

FDA Approves Vanda’s Nereus, First New Motion Sickness Treatment in Over 40 Years

Blood Centers Push for Donors After Holiday Dip as Red Cross Dangles Super Bowl Trip

FDA Grants Priority Review to Axsome’s AXS-05 for Alzheimer’s Agitation, Sets April 30 PDUFA Date

FDA Issues Complete Response Letter for Corcept’s Relacorilant in Cushing’s-Related Hypertension

Statins Cut Deaths and Major Cardiac Events Across Risk Levels in Type 2 Diabetes

FDA-Cleared Wegovy Pill Becomes First Oral GLP-1 for Weight Loss

NYC Health + Hospitals to Merge With Maimonides by April 2026 Pending Approvals

Greg Papa Declines Return to 49ers Radio Booth for Bears Game

FDA Approves First Oral Weight-Loss GLP-1: Wegovy Pill to Launch in January

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

FDA Approves Aqvesme for Thalassemia Anemia, First U.S. Therapy for Both Patient Groups

Longitudinal Study Finds One in Four U.S. Adults Faces Unaffordable Care or Skips Treatment

Donor Support Expands Santa's Visit at Teddy's Place NICU in Annapolis

Neurocrine’s Valbenazine Misses Phase 3 Goals in Dyskinetic Cerebral Palsy

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity